General Information of Drug Therapeutic Target (DTT) (ID: TTM7Y45)

DTT Name Caspase-7 (CASP7)
Synonyms MCH3; ICE-like apoptotic protease 3; ICE-LAP3; CMH-1; CASP-7; Apoptotic protease Mch-3
Gene Name CASP7
DTT Type
Clinical trial target
[1]
BioChemical Class
Peptidase
UniProt ID
CASP7_HUMAN
TTD ID
T72252
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 3.4.22.60
Sequence
MADDQGCIEEQGVEDSANEDSVDAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQY
NMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQ
DLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKL
FFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSW
FVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELY
FSQ
Function
Cleaves and activates sterol regulatory element binding proteins (SREBPs). Proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217' bond. Overexpression promotes programmed cell death. Involved in the activation cascade of caspases responsible for apoptosis execution.
KEGG Pathway
Apoptosis (hsa04210 )
Apoptosis - multiple species (hsa04215 )
TNF signaling pathway (hsa04668 )
Non-alcoholic fatty liver disease (hsa04932 )
Alzheimer disease (hsa05010 )
Pathways of neurodegeneration - multiple diseases (hsa05022 )
Pathogenic Escherichia coli infection (hsa05130 )
Salmonella infection (hsa05132 )
Pertussis (hsa05133 )
Legionellosis (hsa05134 )
Pathways in cancer (hsa05200 )
Lipid and atherosclerosis (hsa05417 )
Reactome Pathway
SMAC (DIABLO) binds to IAPs (R-HSA-111463 )
SMAC(DIABLO)-mediated dissociation of IAP (R-HSA-111464 )
Apoptotic cleavage of cellular proteins (R-HSA-111465 )
SMAC, XIAP-regulated apoptotic response (R-HSA-111469 )
Caspase-mediated cleavage of cytoskeletal proteins (R-HSA-264870 )
Activation of caspases through apoptosome-mediated cleavage (R-HSA-111459 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
isatin sulfonamide 34 DM21Y8J Cystic fibrosis CA25 Clinical trial [1]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
M826 DM9NPE4 Discovery agent N.A. Investigative [2]
------------------------------------------------------------------------------------

References

1 Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem. 2001 Jun 7;44(12):2015-26.
2 Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1173-80.